Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential
Antioxidants · 31.10.2023 · 12 (11) · 1944
DOI: 10.3390/antiox12111944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 31.10.2023. Verfasst von Jamie Francisco und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Die Arbeit wurde bisher 162-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Acute myocardial infarction (MI) occurs when blood flow to the myocardium is restricted, leading to cardiac damage and massive loss of viable cardiomyocytes. Timely restoration of coronary flow is considered the gold standard treatment for MI patients and limits infarct size; however, this intervention, known as reperfusion, initiates a complex pathological process that somewhat paradoxically also contributes to cardiac injury. Despite being a sterile environment, ischemia/reperfusion (I/R) injury triggers inflammation, which contributes to infarct expansion and subsequent cardiac remodeling and wound healing. The immune response is comprised of subsets of both myeloid and lymphoid-derived cells that act in concert to modulate the pathogenesis and resolution of I/R injury. Multiple mechanisms, including altered metabolic status, regulate immune cell activation and function in the setting of acute MI, yet our understanding remains incomplete. While numerous studies demonstrated cardiac benefit following strategies that target inflammation in preclinical models, therapeutic attempts to mitigate I/R injury in patients were less successful. Therefore, further investigation leveraging emerging technologies is needed to better characterize this intricate inflammatory response and elucidate its influence on cardiac injury and the progression to heart failure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
ORCID-Profile: Dominic P Del Re
Förderung
- NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- American Heart Association
Zitieren
APA
Francisco, J., & Del Re, D. P. (2023). Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential. Antioxidants, 12(11), 1944. https://doi.org/10.3390/antiox12111944
Vancouver
Francisco J, Del Re DP. Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential. Antioxidants. 2023;12(11):1944. doi:10.3390/antiox12111944
BibTeX
@article{Francisco2023,
author = {Francisco, Jamie and Del Re, Dominic P},
title = {Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {11},
pages = {1944},
doi = {10.3390/antiox12111944}
}
EUVIMED